🦊/Investors

Genesys Capital

Venture capitaloperating company · company profile

Toronto · Seed–Series B · 12 people tracked

Find your way into Genesys Capital

1,916 people in our graph share verified history with the Genesys Capital team — schools, employers, funds. One of them is your warm intro.

Alex Tranunlockedknows Benjamin Silbert · together at Morgan Stanley (overlapped)
×5knows the team · via Morgan Stanley
×2knows the team · via Creative Destruction Lab
knows the team · via A-Level Capital
knows the team · via The National Institutes of Health
knows the team · via Howard Hughes Medical Institute
Fox Verdict
Sign up to see your fit

Investment thesis

Genesys Capital focuses on the high-growth sectors of biotechnology, pharmaceuticals, and medical technology, investing across the lifecycle from seed to commercial impact. Leveraging over 25 years of experience and long-standing partnerships with leading North American research institutes and universities, the firm gains early access to top-tier scientific discoveries and differentiated deal flow. Genesys often co-creates and builds companies alongside scientific founders and entrepreneurs, acting as a thought partner to shape the future of healthcare. Its strategy aims to deliver strong, repeatable returns to investors while advancing medicine that addresses pressing unmet medical needs.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Series B
Check
$730K – $3.6M
HQ
Toronto, ON, CA
Instruments
Equity
Founded
2000
AUM
$400M
Tracked investments
18
IPOs
1
Acquisitions
3

Team · 12 people

from the firm's website & curated & public directories
Laurie Mak· Associate

What they invest in

from 8 of 18 portfolio companies

Biotech ×6Medical Devices ×6Deep Tech ×4Healthtech ×4Hardware ×2AI & Machine Learning ×1Digital Health ×1

HQs:Canada×4United States×1

Investments · 18 tracked

founders shown can be your intro path

By year:2024 · 12022 · 12 dated

Profound Medicalprofoundmedical.comin𝕏NASDAQ: PROF

Profound Medical develops real-time MRI-guided thermal ultrasound systems for incision-free ablation of abnormal or cancerous tissue.

BiotechDeep TechHealthtechMedical DevicesMississauga

Arun Menawat(CEO and Chairman of the Board)inRashed Dewan(Executive Officer)inMathieu Burtnyk(Chief Operating Officer)inTom Tamberrino(Chief Commercial Officer)

BoardJean-Francois Pariseau(Director)Damian Lamb(Director)

Co-investorsCTI Life Sciences Fund L.P.FACIT (Fight Against Cancer Innovation Trust)

visit www.adapsyn.comadapsyn.comin✓ verified

Adapsyn Bioscience is a biotech company focused on discovering and developing microbial natural product small molecules for therapeutic applications by leveraging genomic and chemical biology approaches.

AI & Machine LearningBiotechDeep TechHamilton, CA

Nathan Magarvey(Founder)

Co-investorsPfizer Venture Investments

Antegrade Medical Incantegrademedical.com

Antegrade Medical is a Quebec City-based medical device startup developing single-use procedural tools enabling an antegrade approach for structural interventional cardiology procedures.

Cryostasis Inccryostasis.ca

Cryostasis develops the Woolii SU (Subzero Unfrozen) platform, a preservation system that stores cell therapy products at subzero temperatures without freezing or cryoprotectants.

BiotechDeep TechHardwareHealthtechMedical Devices

Ebt Medicalebtmedical.comin𝕏

EBT Medical develops neuromodulation technologies targeting the Saphenous nerve to treat pelvic health disorders, particularly overactive bladder.

BiotechMedical Devices

Paul Yoo(Co-founder, President & Chief Scientific Officer)inSasha John(Co-founder and Chief Innovation Officer)inKeith R Carlton(Chief Executive Officer)in

Co-investorsSV Health InvestorsToronto Innovation Acceleration Partners

Enspiredbsenspiredbs.com

Enspire DBS is conducting a clinical trial evaluating Deep Brain Stimulation combined with physical therapy (DBS + Rehab) to assess safety and whether it can improve arm function in stroke patients with lasting impairment.

HealthtechMedical Devices

Co-investorsJobsOhio Ventures

Feldan Therapeuticsfeldan.cominSep 2024

Feldan is a clinical-stage biotech company developing intracellular delivery technologies for therapeutic treatment of diseases.

BiotechDeep TechMedical Devices

François-Thomas Michaud(Board Member & Chief Executive Officer)in

Co-investorsLinearis VenturesFonds de solidarité FTQZynext Ventures

Flosonics Medicalflosonicsmedical.comin𝕏

Flosonics Medical makes FloPatch, a wireless wearable Doppler ultrasound device that assesses a patient's carotid arterial pulse in real time to give clinicians hemodynamic data for fluid resuscitation decisions.

Digital HealthHardwareMedical Devices

Joe Eibl(Founder)in

Co-investorsAmplify CapitalArboretum VenturesiGan PartnersNew Leaf Venture PartnersRBCx

Fusion Pharmaceuticalsfusionpharma.comin𝕏

Fusion Pharma develops targeted alpha therapeutics that link alpha-emitting medical isotopes to molecules targeting biomarkers on cancer cell surfaces to selectively kill tumor cells.

BiotechHealthtech

Co-investorsFACIT (Fight Against Cancer Innovation Trust)HealthCapLumira VenturesSeroba Life SciencesVenture OntarioYsios Capital+2 more

IDbyDNAillumina.comAcquired

Scalable, high throughput DNA sequencing platforms.

Co-investorsARCH Venture PartnersArtis VenturesHemisphere Ventures LLCHeran PartnersSPRINGROCK VENTURESVenrock

Inversagoinversago.comOct 2022acquired by Novo Nordisk

Portfolio company acquired by Novo Nordisk for $1.1B USD.

Co-investorsAmorChemJDRF T1D FundNew Enterprise Associates (NEA)Tarnagulla VenturesadMare BioInnovationsAmgen Ventures+2 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Adapsyn Bioscience IncFunction NeuromodulationFusionGiiantGiiant Pharma IncQuestat IncVeralox Therapeutics Inc

Exits · 4

1 IPOs · 3 acquisitions · showing 3

Profound MedicalNASDAQ: PROFFusionacq. by AlumniInversagoacq. by Novo Nordisk

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Genesys Capital made?
Genesys Capital has 18 tracked investments, 4 of which have exited.
What stage does Genesys Capital invest at?
Genesys Capital invests at the Seed, Series A, Series B stages.
What is Genesys Capital's typical check size?
Genesys Capital typically writes checks of $730K – $3.6M.
What sectors does Genesys Capital focus on?
Genesys Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is Genesys Capital located?
Genesys Capital is headquartered in Toronto, CA.
Who does Genesys Capital co-invest with?
Genesys Capital most often shares deals with Amplify Capital, Arboretum Ventures, JobsOhio Ventures, among 14 tracked co-investors.

Images

Genesys Capital photoGenesys Capital photoGenesys Capital photoGenesys Capital photoGenesys Capital photoGenesys Capital photo

Similar investors

Featured in lists